SPOTLIGHT: FDA OKs eczema foam

The FDA has approved Connetics' Verdeso, a foam therapy for mild to moderate eczema. Connetics says it will start marketing the treatment in the fourth quarter of this year. Report

Suggested Articles

Merck’s TIGIT-blocking prospect and PD-1 med Keytruda shrank tumors in 29% of lung cancer patients who had never tried a checkpoint inhibitor.

Merck's HIF-2α inhibitor, picked up in its $1 billion Peloton buyout, shrank kidney tumors in 36% of patients and showed promise in other tumors, too.

Amunix reported that a single dose of its lead T-cell engager caused caused large HER2-positive tumors to shrink in mice.